Name

TBG Diagnostics

Legal name

TBG Biotechnology Corp.

Website

https://tbgbio.com

Company type

Public

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• HLA typing reagents
• Molecular diagnostics
• Immunogenetics testing
• Transplant diagnostics
• Genetic testing kits

Headquarters

HQ city

Toowong

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. HLA Typing Reagents and Kits: Sale of molecular diagnostic reagents including QzTGSO Nanopore kits, QzNGS Illumina kits, HLAssure SBT kits, ExProbe qPCR kits, and Morgan SSP kits for HLA, HPA, and KIR typing. Products are sold in kit formats with various test counts (24-96 tests per kit). Revenue: $2.33 million.
2. Laboratory Services: TBG Molecular Typing Laboratory provides HLA-typing services with quality assurance, including participation in international proficiency testing programs. Also offers customized genetic testing solutions and welcomes global laboratory partnerships.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

TBG Diagnostics manufactures and sells molecular diagnostic reagent kits for HLA, HPA, and KIR gene typing across five technology platforms: SSP (gel electrophoresis), SBT (Sanger sequencing), qPCR (real-time PCR), NGS (Illumina), and TGS (Oxford Nanopore). The portfolio is complemented by proprietary analysis software, modular automation hardware (DX-A systems), and ASHI-certified laboratory typing services for clinical labs, transplant centers, and blood banks.

Product overview

TBG Biotechnology Corp. is a molecular diagnostics company focused on immunogenetics, offering a comprehensive portfolio of HLA (Human Leukocyte Antigen), HPA (Human Platelet Antigen), and KIR gene typing products. The product ecosystem spans five technology platforms: QzTGSO (Third Generation Sequencing using Oxford Nanopore), QzNGS (Next Generation Sequencing using Illumina), HLAssure SBT (Sanger Sequence Based Typing), ExProbe (Real Time PCR/qPCR), and Morgan (Sequence Specific Primers with gel electrophoresis). Each platform is supported by corresponding analysis software (QzTGStype, QzNGStype, AccuType, and ExProbeType) for data interpretation. The portfolio also includes automation hardware (DX-A Autopipetting System, DX-A Mini TGS Library Prep) and laboratory services, providing end-to-end solutions for transplantation, transfusion, autoimmunity, drug hypersensitivity, and genetic disease testing including NIPT, Thalassemia, Sickle Cell Anemia, SMA, and Fragile X Syndrome.

Differentiator

Problem solved

Functional benefit

Brands

• QzTGSO: Third Generation Sequencing (TGS) HLA typing kits using Oxford Nanopore Technologies sequencer for full-length amplicon phasing with 4-hour turnaround time
• QzNGS
• HLAssure
• Morgan
• ExProbe
• DX-A Autopipetting System
• DX-A Mini TGS Library Prep
• QzTGStype
• AccuType
• ExProbeType

Products and services

• QzTGSO Typing Kits Third Generation Sequencing (TGS) HLA typing kits designed to run on Oxford Nanopore Technologies sequencers, providing full-length amplicon phasing and 100% fully phased results within 4 hours for clinical HLA typing laboratories and transplant centers.
• QzNGS Typing Kits Next Generation Sequencing kits using Illumina sequencers for high resolution HLA typing with pair-end short reads enabling long distance phasing for ultra-high throughput processing (up to 384 barcodes per run).
• HLAssure SBT Kits Sequence Based Typing kits using Sanger sequencing with Group Specific Amplification (GSA) primers for high resolution HLA genotyping across A, B, C, DRB1, DQB1, DPB1, DRB3/4/5, DQA1, DPA1, and HPA loci. Includes IVD clearance for European CE, Taiwan FDA, and China FDA.
• ExProbe Typing Kits Real Time PCR (qPCR) typing kits for rapid HLA, HPA, and KIR allele detection with results within 2 hours, using TaqMan or Melting Curve Analysis formats across multiple real-time PCR instrument platforms.
• Morgan HLA SSP Kits Sequence Specific Primer kits using agarose gel electrophoresis for low-medium resolution HLA typing, providing the most economical solution for low-throughput processing with results within 3.5 hours.
• DX-A Autopipetting System Modular automation pipettor system weighing under 25 kg that can be linked together for flexible and scalable automated sample dilution and processing, reducing hands-on time and human variability.
• DX-A Mini TGS Library Prep Compact automated TGS library preparation system smaller than a microwave oven, processing up to 32 samples in a single run with reduced hands-on time and high efficiency.
• TBG Molecular Typing Laboratory Services ASHI-certified HLA-typing services with highest level of quality assurance, participation in international proficiency testing programs, and customized genetic testing solutions offered through global laboratory partnerships.

Quantifiable outcome

• Single sample Turn Around Time within 4 hours with TGS Nanopore platform
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability1 record

Feature8 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Asian Society for Clinical Pathologist and Laboratory Medicine (ASCPaLM)flagshipStrategic or Co-development Partner · 2 October 2025TBG Biotechnology serves as the host/organizer for ASCPaLM 2026 conference to be held at Taipei International Convention Center. TBG's President delivers remarks welcoming members to the society's global platform for collaboration, innovation, and excellence in clinical pathology and laboratory medicine.
• Oxford Nanopore Technologies (ONT)coreTechnology or IntegrationOxford Nanopore Technologies supplies the sequencer platform for TBG's QzTGSO Typing Kits. TBG products use ONT's MinION flow cell technology which can be reloaded up to 6 times. TBG recommends purchasing Nanopore equipment and consumables directly from local ONT suppliers.
• IlluminacoreTechnology or IntegrationIllumina provides the sequencing platform for TBG's QzNGS Typing Kits. The pair-end short read technology from Illumina enables cost-efficient high throughput testing. TBG recommends purchasing Illumina equipment from authorized suppliers.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• HistoGenetics: HistoGenetics is an ASHI-accredited reference laboratory providing high-resolution HLA typing services. Directly comparable to TBG's TBG Molecular Typing Laboratory service business serving transplant and research customers globally.
• Omixon: Omixon offers Holotype HLA NGS kits and the HLA Twin software platform for clinical HLA typing. Directly comparable to TBG's NGS workflow offering and a peer in software-driven immunogenetics analysis.
• Thermo Fisher Scientific (One Lambda): Through its One Lambda business, Thermo Fisher is the global market leader in HLA typing reagents and transplant diagnostics, offering LABType SSO, SeCore SBT, and AlleleSEQR PCR products. Directly comparable to TBG as a reagent vendor for clinical HLA typing labs.
• GenDx: GenDx specializes in NGS-based HLA and KIR typing reagents (NGmix, AlleleID) along with analysis software (SBTengine, NGSengine). A near-direct competitor to TBG's QzNGS and HLAssure SBT product lines in transplant labs.
• Immucor: Immucor (acquired by Stago) provides transfusion and transplant diagnostics including HLA serology and molecular reagents for blood banks and transplant centers. Directly comparable to TBG on HLA/HPA reagents for transfusion and transplant labs.
• Bio-Rad Laboratories: Bio-Rad offers the HLA SSO and Luminex-based typing products (formerly Bio-Rad/AbD Serotec) used widely in transplant and immunogenetics labs. Competes head-to-head with TBG's SSP, SBT, and NGS HLA kits across clinical laboratories worldwide.
• BAG Diagnostics: BAG Diagnostics provides HLA typing kits based on SSP and SSO methods for clinical and research labs. Comparable as a niche HLA reagent vendor competing with TBG's Morgan SSP and HLAssure product lines, particularly in Europe.

Emerging players

• Scisco Genetics: Scisco Genetics offers HLA and KIR SSP typing kits primarily for research and clinical labs. A niche molecular HLA reagent peer with similar low-to-medium resolution offering to TBG's Morgan SSP kit line.

Broad incumbents

• QIAGEN: QIAGEN provides molecular diagnostic reagents, sample prep kits, and HLA-related assays as part of a broad life sciences portfolio. Comparable to TBG on molecular diagnostic reagents and laboratory automation, though HLA is not its primary focus.
• CareDx: CareDx is a transplant-focused diagnostics company offering AlloMap and AlloSure along with lab services for transplant centers. Comparable as a transplant diagnostics peer though operating more downstream in patient monitoring rather than donor-recipient HLA typing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tbg-diagnostics-ltd

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TBG Diagnostics